RxDoctor Payments Data

Seth Williams, APRN

Nurse Practitioner · Grand Island, NENPI 1093425670

Payments from drug & device makers

$1,234in general payments, 2019–2025

Across 78 payments — averaging $15.82 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Stryker$170
  • AbbVie$137
  • AstraZeneca$104
  • Bayer$85
  • Otsuka America Pharmaceutical, Inc.$84
  • Pfizer$84
  • plus $570 from 20 others

What the payments were for

  • Food & beverage$1,234100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,234 in reported general payments places this provider in the 75th percentile of 924 nurse practitioner providers in Nebraska.

See all nurse practitioner providers in Nebraska

Medicare billing

Part B allowed, 2024
$29,669
Medicare patients
208
Services billed
456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin15$6,674
EliquisApixaban11$5,835
Fluticasone Propionate24$336
Atorvastatin Calcium35$321
Gabapentin16$191
Metoprolol Succinate16$152
Chlorhexidine Gluconate12$145
Lisinopril24$121
Amiodarone Hcl14$116
Amlodipine Besylate18$102
Furosemide29$92
Montelukast Sodium18$84
Rosuvastatin Calcium15$76
Lisinopril-HydrochlorothiazideLisinopril/Hydrochlorothiazide11$69
Hydrochlorothiazide17$53

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$84$5,83511 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 924 nurse practitioner providers in Nebraska.

Other nurse practitioner in Grand Island

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →